Glenmark Pharmaceuticals Posts ₹354.4 Crore Profit in Q2

18 Nov 2024 , 10:45 AM

Glenmark pharmaceuticals limited has reported a net profit of ₹354.4 Crore in it’s Q2 report which was released on Thursday. This Indian pharmaceutical company has released it’s second quarter result that ended on September 30, 2024. The company also reported revenue from operations to ₹3433.7 Crore. The EBITDA margin for the quarter that ended on September 30, 2024 stands at 17.5%.

In the corresponding quarter of the previous financial year, Glenmark pharmaceuticals has reported a net loss of ₹180 crore. Based on the data from the company that was shared in the regulatory filing, operations for the corresponding quarter in the previous financial year was ₹3207 Crore.

When coming to the Segment wise contribution, this Indian pharmaceutical company has reported a sales of ₹1281 Crore in the Q2. This sales report has contributed to 37.3% overall revenue growth for Glenmark.

In the National Stock Exchange, Glenmark Pharmaceuticals shares are currently trading at ₹1526 which is a 0.54% drop than the previous close. Glenmark pharmaceuticals has gained the total of 94% in the last one year and 78% since the beginning of the Year.